Compare RLGT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLGT | CYRX |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.6M | 438.7M |
| IPO Year | N/A | N/A |
| Metric | RLGT | CYRX |
|---|---|---|
| Price | $6.72 | $9.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $8.00 | ★ $12.83 |
| AVG Volume (30 Days) | 153.6K | ★ 594.0K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.35 | N/A |
| EPS | 0.31 | ★ 1.27 |
| Revenue | ★ $925,786,000.00 | $243,795,000.00 |
| Revenue This Year | $3.77 | N/A |
| Revenue Next Year | $3.51 | $9.26 |
| P/E Ratio | $21.97 | ★ $7.44 |
| Revenue Growth | 16.42 | ★ 41.27 |
| 52 Week Low | $5.44 | $4.58 |
| 52 Week High | $7.94 | $11.44 |
| Indicator | RLGT | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 68.13 | 49.73 |
| Support Level | $6.31 | $9.08 |
| Resistance Level | $6.49 | $10.30 |
| Average True Range (ATR) | 0.16 | 0.46 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 83.16 | 42.94 |
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.